Recommendation ID
NG230/07
Question

Imaging for further staging: For people with differentiated thyroid cancer who have initial ultrasound evidence of extensive local spread (T2N1), what is the clinical and cost effectiveness of CT, MRI or F-18 FDG PET-CT scanning, with or without ultrasound, as part of a further staging strategy?

Any explanatory notes
(if applicable)

For a short explanation of why the committee made this recommendation for research, see the rationale section on imaging for further staging.

Full details of the evidence and the committee's discussion are in evidence review G: imaging for further staging.


Source guidance details

Comes from guidance
Thyroid cancer: assessment and management
Number
NG230
Date issued
December 2022

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 31/12/2022